TVTX
Travere Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$50.39
−0.36%Forward multiples
Based on analyst estimates
- P/E forward
- 19.11x
- P/E 2026E
- —
- P/E 2027E
- 17.88x
- P/E 2028E
- 11.87x
- P/S forward
- 4.54x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 193.70x
- Price / sales
- 8.03x
- Price / cash flow
- 51.24x
Enterprise value
- Enterprise value
- $4.9B
- EV / sales
- 8.25x
- EV / EBITDA
- 844.16x
- EV / EBIT
- -120.56x
- Market cap
- $4.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026